Matthew Klein Sells 8,089 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock

Matthew Klein Sells 8,089 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock

PTC Therapeutics, Inc. (NASDAQ:PTCT - Get Free Report) CEO Matthew Klein sold 8,089 shares of the business's stock in a transaction on Tuesday, December 30th. The shares were sold at an average price of $76.64, for a total transaction of $619,940.96. Following the completion of the transaction, the chief executive officer owned 341,875 shares in the company, valued at approximately $26,201,300. The trade was a 2.31% decrease in their position. T…